RETAKLIK (Retatrutide) is a next-generation triple agonist peptide designed for advanced metabolic research. Acting across GLP-1, GIP, and glucagon pathways, it is widely studied for its role in appetite signalling, energy expenditure, and glucose metabolism. The 40mg format provides a high-strength option for extended research protocols.

Key Research Areas:

• Appetite regulation
• Weight management pathways
• Glucose metabolism
• Energy expenditure

All products are sold strictly for research purposes only. Purchasers must be 21 years of age or older.